Crystal-induced acute renal failure

American Journal of Medicine

Volumn 106, Issue 4, 1999, Pages 459-465

  Perazella, Mark A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; INDINAVIR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONAMIDE; TRIAMTERENE;

ACIDURIA; ACUTE KIDNEY FAILURE; BLOOD VOLUME; CRYSTAL; CRYSTALLIZATION; DIALYSIS; DRUG DOSE; DRUG MEGADOSE; HUMAN; HYPOALBUMINEMIA; INTRAVENOUS DRUG ADMINISTRATION; MICTURITION; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRECIPITATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ACYCLOVIR; HUMANS; INDINAVIR; KIDNEY; KIDNEY FAILURE, ACUTE; METHOTREXATE; RISK; SULFONAMIDES; TRIAMTERENE;

EID: 0033119860     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00041-8     Document Type: Review

References (53)

1. Berns J.S., Cohen R.M., Stumacher R.J., Rudnick M.R. Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections. J Am Soc Nephrol. 1:1991;1061-1080.
2. Conger J.D. Acute uric acid nephropathy. Med Clin North Am. 74:1990;384-392.
3. Sawyer M.H., Webb D.E., Balow J.E., Straus S.E. Acyclovir-induced renal failure. Clinical course and histology. Am J Med. 84:1988;1067-1071.
4. Brigden D., Rosling A.E., Woods N.C. Renal function after acyclovir intravenous injection. Am J Med. 73:(suppl 1A):1982;182-185.
5. Keeney R.F., Kirk L.E., Brigden D. Acyclovir tolerance in humans. Am J Med. 73:(suppl 1A):1982;176-181.
6. Bean B., Aeppli D. Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster. J Infect Dis. 151:1985;362-365.
7. Spiegel D., Lau K. Acute renal failure and coma secondary to acyclovir therapy. J Am Med Assoc. 255:1986;1882-1883.
8. Krieble B.F., Rudy D.W., Glick M.R., Clayman M.D. Acyclovir neurotoxicity and nephrotoxicity-the role for hemodialysis. Am J Med Sci. 305:1993;36-39.
9. Dos Santos M., Dos Santos O.F., Boim M.A., et al. Nephrotoxicity of acyclovir and ganciclovir in rats evaluation of glomerular hemodynamics. J Am Soc Nephrol. 8:1997;361-367.
10. Becker B.N., Fall P., Hall C., Milarn D., Leonard J., Glick A., Schulman G. Rapidly progressive acute renal failure due to acyclovir case report and review of the literature. Am J Kidney Dis. 22:1993;611-615.
11. Giustina A., Romanelli G., Cimino A., Brunon G. Low dose acyclovir and acute renal failure. Ann Intern Med. 108:1988;312. Letter.
12. Eck P., Silver S.M., Clark E.C. Acute renal failure and coma after a high dose of oral acyclovir. NEJM. 325:1991;1178. Letter.
13. Simon D.I., Brosius F.C., Rothstein D.M. Sulfadiazine-induced crystalluria revisted. The treatment of Toxoplasma encephalitis in patients with acquired immune defiency syndrome. Arch Intern Med. 150:1990;2379-2384.
14. Carbone L.G., Bendixen B., Appel G.B. Sulfadiazine-associated obstructive nephropathy occurring in a patient with acquired immune deficiency syndrome. Am J Kidney Dis. 12:1988;72-75.
15. Hein R., Brunkhorst R., Thon W.F. Symptomatic sulfadiazine crystalluria in AIDS patients a report of two cases. Clin Nephrol. 39:1993;254-256.
16. Sasson J.P., Dratch P.L., Shortsleeve M.J. Renal ultrasound findings in sulfadiazine-induced crystalluria. Radiology. 185:1992;739-740.
17. Molina J.M., Belenfant X., Doco-Lecompte T. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis. AIDS. 5:1991;587-589.
18. Buchanan N. Sulfamethoxazole, hypoalbuminemia, crystalluria, and renal failure. BMJ. 2:1978;172. Letter.
19. Siegel W.H. Unusual complications of therapy with sulfamethoxazole-trimethoprim. J Urol. 117:1977;397-399.
20. de Sequera P., Albalate M., Hernandez J., et al. Acute renal failure due to sulfadiazine crystalluria in AIDS patients. Post Med J. 72:1996;557-558.
21. Diaz F., Collazos J., Mayo J., Martinez E. Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and Toxoplasma encephalitis. Ann Pharmacol. 30:1996;41-42.
22. Garnick M.B., Mayer R.J., Abelson H.T. Acute renal failure associated with cancer treatment. Brenner B.M., Lazarus J.M., Acute Renal Failure. 2nd ed. 1988;636-645 Churchill Livingstone, New York.
23. Pitman S.W., Frei E. Weekly methotrexate-calcium leukovorin rescue. Effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma. Cancer Treat Rep. 61:1977;695-701.
24. Pitman S.W., Parker L.M., Tattersall M.H.N. Clinical trial of high dose methotrexate with citovorum factor toxicologic and therapeutic observations. Cancer Chemother Rep. 6:1975;43-49.
25. Abelson H.T., Fosburg M.T., Beardsley P. Methotrexate-induced renal impairment clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol. 1:1983;208-216.
26. Sand T.E., Jacobsen S. Effect of urine pH and flow on renal clearance of methotrexate. Eur J Clin Pharmacol. 19:1981;453-456.
27. Link D.A., Foxburg M.T., Ingelfinger J.R. Renal toxicity of high-dose methotrexate. Pediatr Res. 10:1976;455. Abstract.
28. Hande K.R., Balow J.E., Drake J.C. Methotrexate and hemodialysis. Ann Intern Med. 87:1977;495-496.
29. Wall S.M., Johansen M.J., Molony D.A., Dubose T.D., Jaffe N., Madden T. Effective clearance of methotrexate using high-flux hemodialysis membranes. Am J Kidney Dis. 28:1996;846-854.
30. Gulick R., Mellors J., Havlir D., et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. NEJM. 337:1997;734-739.
31. Tashima K.T., Horowitz J.D., Rosen S. Indinavir nephropathy. NEJM. 336:1997;138-139. Letter.
32. Perazella M.A., Kashgarian M., Cooney E. Indinavir nephropathy in an HIV-infected patient with renal insufficiency and pyuria. Clin Nephrol. 50:1998;194-196.
33. Daudon M, Estepa L, Viard JP, Joly D, Jungers P. Urinary stones in HIV-1 positive patients treated with indinavir. Lancet. 1997;349:1294-1205.
34. Kopp J.B., Miller K.D., Mican J.A., et al. Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med. 127:1997;119-125.
35. Bach M.C. Indinavir nephrolithiasis in warm climates. J AIDS. 14:1997;296-297. Letter.
36. Berns J.S., Cohen R.M., Silverman M., Turner J. Acute renal failure due to indinavir crystalluria and nephrolithiasis report of two cases. Am J Kidney Dis. 30:1997;558-560.
37. Grunke M., Valerius T., Manger B., Kalden J.R., Harrer T. Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavir. Clin Infect Dis. 25:1997;1270-1271.
38. Fairley K.F., Woo K.T., Birch D.F., Leaker B.R., Ratnaike S. Trianterene-induced crystalluria and cylinduria clinical and experimental studies. Clin Nephrol. 26:1986;169-173.
39. Sica D.A., Gehr T.W.B. Triamterene and the kidney. Nephron. 51:1989;454-461.
40. Fairley K.F., Birch D.F., Haines I. Abnormal urinary sediment in patients on Triamterene. Lancet. i:1983;421-422.
41. Ettinger B., Oldroyd N.O., Sorgel F. Triamterene nephrolithiasis. J Am Med Assoc. 244:1980;2443-2445.
42. Grunberg R.W., Silberg S.J. Triamterene-induced nephrolithiasis. J Am Med Assoc. 245:1981;2494-2495.
43. White D.J., Nancollas G.H. Triamterene and renal stone formation. J Urol. 127:1982;593-597.
44. Favre L., Glasson P., Vallotton M.B. Reversible acute renal failure from combined triamterene and indomethacin. Ann Intern Med. 96:1982;317-320.
45. Weinberg M.S., Quigg R.J., Salant D.J., Bernard D.B. Anuric renal failure precipitated by indomethacin and triamterene. Nephron. 40:1985;216-218.
46. Spence J.D., Wong D.G., Lindsay R.M. Effects of triamterene and amiloride on urinary sediment in hypertensive patients taking hydrochlorthiazide. Lancet. I:1985;73-75.
47. Farge D., Turner M.W., Roy D.R., Jothy S. Dyazide-induced reversible acute renal failure associated with intracellular crystal deposition. Am J Kidney Dis. 8:1986;445-449.
48. Roy L.F., Villeneuve J.P., Dumont A., et al. Irreversible renal failure associated with triamterene. Am J Nephrol. 11:1991;486-488.
49. Fogazzi G.B. Crystalluria a neglected aspect of urinary sediment analysis. Nephrol Dial Transplant. 11:1996;379-387.
50. Maurice-Estepa L., Daudon M., Katlama C., et al. Identification of crystals in kidneys of AIDS patients treated with foscarnet. Am J Kidney Dis. 32:1998;392-400.
51. Perazella M.A., Brown E. Electrolyte and acid-base disorders associated with AIDS an etiologic review. J Gen Intern Med. 9:1994;232-236.
52. Schilsky R.L. Renal and metabolic toxicities of cancer chemotherapy. Sem Oncol. 9:1982;75-83.
53. Narins R.G., Carley M., Bloom E.J., Harrison D.S. The nephrotoxicity of chemotherapeutic agents. Sem Nephrol. 10:1990;556-564.